Recombinant Mouse Defb4 Protein ，His & SUMO

Defb4, also known as antimicrobial peptide Defensin beta 4, is a crucial component of the innate immune system, primarily expressed in epithelial tissues such as the skin and mucosal surfaces. Its primary function is to provide a first line of defense against microbial infections by exhibiting broad-spectrum antimicrobial properties, including antibacterial, antifungal, and antiviral activities. Research interest in Defb4 has surged due to its potential therapeutic applications, particularly in the context of increasing antibiotic resistance and rising infectious diseases. The peptide works by disrupting microbial membranes and modulating host immune responses, suggesting its role not only as a direct antimicrobial agent but also as an immunomodulator. Recent studies have focused on the recombination and production of Defb4 in various expression systems, which allows for detailed structural and functional analysis. Understanding its mechanisms can pave the way for the development of novel antimicrobial drugs and enhance current therapies against pathogens that have developed resistance to conventional antibiotics. Moreover, exploring the genetic regulation of Defb4 expression can provide insights into its role in diseases characterized by dysregulated immune responses, such as chronic inflammation and cancer. Overall, the study of recombinant Defb4 represents a promising frontier in both basic research and clinical applications, highlighting the need for continued exploration of its potential as a versatile therapeutic agent in modern medicine.